You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 63 No. 2, February 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Movement Disorders
 •Parkinson Disease/ Parkinsonian Disorders
 •Psychiatry
 •Obsessive-Compulsive Disorder
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic

REGULAR CORRESPONDENCE
Impulse Control Disorders and Dopaminergic Drugs

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We read with interest the article by Dodd et al.1 Impulse control disorders associated with dopaminergic drugs in Parkinson disease (PD) are fascinating and of considerable clinical importance. This report, however, focuses on dopamine agonists and especially pramipexole. Although dopamine agonists are more commonly implicated in impulse control disorders, we would like to point out that levodopa is associated with similar behaviors as well.2-4

Three years after the introduction of levodopa, Andén et al2 reported a man with PD who developed compulsive hammering of nails into the doors and walls after his dose of levodopa was increased. The punding behavior resolved when his levodopa dose was lowered.2 This report precedes the use of dopamine agonists in PD. Levodopa was also associated with pathological gambling in a series of 12 patients reported by Molina et al.3 The gambling compulsion occurred typically in the "on" state for these patients and would frequently . . . [Full Text of this Article]

AUTHOR INFORMATION

John C. Morgan, MD, PhD; Sanjay S. Iyer, MD; Kapil D. Sethi, MD, FRCP(UK)


RELATED ARTICLES

Impulse Control Disorders and Dopaminergic Drugs—Reply
M. Leann Dodd, Kevin J. Klos, James H. Bower, Yonas E. Geda, Keith A. Josephs, and J. Eric Ahlskog
Arch Neurol. 2006;63(2):299.
EXTRACT | FULL TEXT  

Pathological Gambling Caused by Drugs Used to Treat Parkinson Disease
M. Leann Dodd, Kevin J. Klos, James H. Bower, Yonas E. Geda, Keith A. Josephs, and J. Eric Ahlskog
Arch Neurol. 2005;62(9):1377-1381.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.